Soleno Therapeutics, Inc. (SLNO)

NASDAQ: SLNO · IEX Real-Time Price · USD

39.73

-2.56 (-6.05%)

At close: Jul 2, 2024, 4:00 PM

41.80

+2.07 (5.21%)

After-hours: Jul 2, 2024, 7:06 PM EDT

Soleno Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2012
Net Income	-38.99	-24.07	-30.91	-24.64	-30.77	Upgrade
Depreciation & Amortization	2.28	2.25	2.25	2.24	2.34	Upgrade
Share-Based Compensation	5.95	2.53	3.28	1.5	0.83	Upgrade
Other Operating Activities	5.82	-1.5	-2.39	-4.32	10.23	Upgrade
Operating Cash Flow	-24.94	-20.78	-27.77	-25.22	-17.38	Upgrade
Capital Expenditures	0	-0.01	-0.02	-0.01	-0.02	Upgrade
Acquisitions	0	0	0	0	0.5	Upgrade
Other Investing Activities	-	-	-	-	0.05	Upgrade
Investing Cash Flow	0	-0.01	-0.02	-0.01	0.53	Upgrade
Share Issuance / Repurchase	180.02	14.11	0	53.74	14.48	Upgrade
Debt Issued / Paid	0	0	-0.01	-0.02	-0	Upgrade
Other Financing Activities	-	-0.02	-0.12	-	-	Upgrade
Financing Cash Flow	180.02	14.09	-0.13	53.72	14.48	Upgrade
Net Cash Flow	155.08	-6.7	-27.92	28.49	-2.37	Upgrade
Free Cash Flow	-24.94	-20.79	-27.79	-25.23	-17.4	Upgrade
Free Cash Flow Per Share	-1.51	-2.48	-5.23	-6.04	-7.64	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).